Researchers have found a link between social determinants of health and survival outcomes in patients with NSCLC. Following new protocols allows for many lung cancer patients to leave the hospital 1 day after surgery. Early menopause, shortened reproductive span, and other reproductive factors were linked to risk of lung cancer in women. The combination of durvalumab plus concurrent radiotherapy shows promising in treating NSCLC. Three patient case reports showed that osimertinib is a promising and viable treatment option for lung cancer with bone mets. A study assessed the link between osimertinib and VEGF expression in patients with advanced non-small cell lung cancer. Osimertinib treatment was safe and effective in patients with advanced small-cell lung cancer treated amid the pandemic. The panel uses the ADAURA trial as a springboard to address clinical trial designs. Jill Feldman, a lung cancer survivor and co-founder of the EGFR Resisters advocacy group, details her lung cancer journey. JK5G postbiotics may improve gut microbiota, QOL, and appetite in patients with advanced NSCLC on PD-1 inhibitor therapy. Researchers used a radiomics approach to predict brain metastases in lung cancer patients. The Oncology Brothers discuss findings from the phase 3 ADAURA trial. Dr. Patrick Forde spoke with DocWire News at ASCO 2023 about updated data from the CheckMate 816 trial. The Oncology Brothers highlight three studies from the recent American Association for Cancer Research (AACR) 2023 ... The group makes the distinction between non-small cell lung cancer, used as an umbrella term, and small cell lung cancer. In a recent study, published in Thoracic Cancer, researchers evaluated the safety and efficacy of osimertinib plus ... In a recent meta-analysis, published in Cancer, researchers evaluated neoadjuvant immunotherapy in patients with ... In this episode, the Oncology Brothers speak with world-renowned thoracic oncologist Dr. Jarushka Naidoo of Royal ... Lung cancer is one of the most common and deadly malignancies found in oncology, making early detection critical. The third episode in this series answers: What do you do when performing a biopsy on a suspected metastatic lesion?